Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Endoscopic Suturing Devices Market Strategic Research Report

Global Medical Endoscopic Suturing Devices Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Endoscopic Suturing Devices Market
$62.572025
12.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Disposable, Reusable

By Application: Bariatric Surgery, Gastrointestinal Surgery, Gasteoesophageal Reflux Disease Surgery, Other Surgeries

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Apollo Endosurgery, Inc., Johnson&Johnson Services, Inc., Cook Group, USGI Medical, Endo Tools Therapeutics S.A., Boston Scientific, Stryker, Ergosuture, Sutrue Limited, Ovesco Endoscopy

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$62.57
Million USD
Forecast CAGR
12.4%
2025-2032
Forecast 2032
$141.8
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Medical Endoscopic Suturing Devices market size is predicted to grow from US$ 62.57 million in 2025 to US$ 140 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.

The medical endoscopic suturing devices is used in endoscopic surgery to place interrupted or continuous sutures in soft tissues.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The market for medical endoscopic suturing devices is driven by several key factors such as increasing prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and vascular diseases such as arteries and veins. The need for treatment options where endoluminal suturing devices excel. Advances in medical technology have led to the development of more complex and efficient endoluminal suturing devices, increasing their safety and efficacy. These devices offer greater suturing precision and greater control during surgery, appealing to healthcare providers and patients seeking better treatment outcomes. Rising geriatric population across the globe has contributed significantly to the growth of the market. Older adults are more prone to gastrointestinal and vascular problems and thus require increased use of endoluminal suturing devices to meet their specific medical needs. Moreover, growing preference for minimally invasive procedures is generally driving the demand for endoluminal suturing devices. Patients and physicians alike are seeking alternatives to traditional open surgery due to the reduced postoperative complications, faster recovery time, and shorter hospital stays associated with minimally invasive approaches. Healthcare cost containment initiatives by governments and insurance providers have driven healthcare organizations to adopt cost-effective technologies, making endoluminal suturing devices an attractive option due to their potential to reduce overall treatment costs compared to open surgery. Rising awareness among healthcare professionals regarding the benefits of endoluminal suturing devices and ongoing efforts by manufacturers to improve device design and accessibility also contribute to the growth of the market. Overall, medical necessity, technological advancements, demographic trends, patient preferences, cost considerations, and rising awareness combine to drive the growth of this market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Endoscopic Suturing Devices market?

What factors are driving Medical Endoscopic Suturing Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Endoscopic Suturing Devices market opportunities vary by end market size?

How does Medical Endoscopic Suturing Devices break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Endoscopic Suturing Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Disposable
  • Reusable

Segment by Application

  • Bariatric Surgery
  • Gastrointestinal Surgery
  • Gasteoesophageal Reflux Disease Surgery
  • Other Surgeries

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Endoscopic Suturing Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Bariatric Surgery, Gastrointestinal Surgery, Gasteoesophageal Reflux Disease Surgery evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Endoscopic Suturing Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$62.57
2025
Forecast
$141.8
2032
CAGR
12.4%
2025–2032
リージョン
5
global
Key companies
MedtronicApollo Endosurgery, Inc.Johnson&Johnson Services, Inc.Cook GroupUSGI MedicalEndo Tools Therapeutics S.A.Boston ScientificStryker
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
DisposableReusable
By Application
Bariatric SurgeryGastrointestinal SurgeryGasteoesophageal Reflux Disease SurgeryOther Surgeries

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Disposable
  • 3.1.3 Reusable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Bariatric Surgery
  • 4.1.3 Gastrointestinal Surgery
  • 4.1.4 Gasteoesophageal Reflux Disease Surgery
  • 4.1.5 Other Surgeries
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Apollo Endosurgery,Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Johnson&Johnson Services,Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cook Group
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 USGI Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Endo Tools Therapeutics S.A.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Boston Scientific
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Stryker
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ergosuture
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sutrue Limited
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Ovesco Endoscopy
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Medical Endoscopic Suturing Devices market size?
The global Medical Endoscopic Suturing Devices market is estimated at US$ 62.57 million in 2025 (base year) and is projected to reach US$ 140 million by 2032.
What growth rate is expected for the Medical Endoscopic Suturing Devices market through 2032?
The market is expected to grow at a CAGR of 12.4% from 2026 to 2032, expanding from US$ 62.57 million in 2025 to US$ 140 million in 2032, roughly 2.2 times its base-year value.
How is Medical Endoscopic Suturing Devices defined?
The medical endoscopic suturing devices is used in endoscopic surgery to place interrupted or continuous sutures in soft tissues.
How is the Medical Endoscopic Suturing Devices market segmented by type?
By type, the market is segmented into Disposable and Reusable.
What are the key applications of Medical Endoscopic Suturing Devices?
Key applications covered include Bariatric Surgery, Gastrointestinal Surgery, Gasteoesophageal Reflux Disease Surgery and Other Surgeries.
Which companies are profiled in the Medical Endoscopic Suturing Devices market report?
Key players profiled include Medtronic, Apollo Endosurgery, Johnson&Johnson Services, Cook Group, USGI Medical, Endo Tools Therapeutics S.A., Boston Scientific and Stryker, among 11 companies covered in total.
What geographies does the Medical Endoscopic Suturing Devices market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Medical Endoscopic Suturing Devices?
The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Who should buy the Medical Endoscopic Suturing Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in Bariatric Surgery, Gastrointestinal Surgery and Gasteoesophageal Reflux Disease Surgery, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Endoscopic Suturing Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.